Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity.
Tedeschi R, Pin E, Martorelli D, Bidoli E, Marus A, Pratesi C, Bortolin MT, Zanussi S, Vaccher E, Dolcetti R, De Paoli P. Tedeschi R, et al. Among authors: dolcetti r. Clin Vaccine Immunol. 2007 Apr;14(4):435-41. doi: 10.1128/CVI.00466-06. Epub 2007 Feb 28. Clin Vaccine Immunol. 2007. PMID: 17329446 Free PMC article.
High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.
Caggiari L, Guidoboni M, Vaccher E, Barzan L, Franchin G, Gloghini A, Martorelli D, Zancai P, Bortolin MT, Mazzucato M, Serraino D, Carbone A, De Paoli P, Dolcetti R. Caggiari L, et al. Among authors: dolcetti r. Infect Agent Cancer. 2007 Mar 1;2:5. doi: 10.1186/1750-9378-2-5. Infect Agent Cancer. 2007. PMID: 17331231 Free PMC article.
Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.
Martorelli D, Houali K, Caggiari L, Vaccher E, Barzan L, Franchin G, Gloghini A, Pavan A, Da Ponte A, Tedeschi RM, De Re V, Carbone A, Ooka T, De Paoli P, Dolcetti R. Martorelli D, et al. Among authors: dolcetti r. Int J Cancer. 2008 Sep 1;123(5):1100-7. doi: 10.1002/ijc.23621. Int J Cancer. 2008. PMID: 18546263 Free article.
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes.
Pasini E, Caggiari L, Dal Maso L, Martorelli D, Guidoboni M, Vaccher E, Barzan L, Franchin G, Gloghini A, De Re V, Sacchi N, Serraino D, Carbone A, Rosato A, Dolcetti R. Pasini E, et al. Among authors: dolcetti r. Int J Cancer. 2009 Sep 15;125(6):1358-64. doi: 10.1002/ijc.24515. Int J Cancer. 2009. PMID: 19536817 Free article.
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Muraro E, Martorelli D, Turchet E, Miolo G, Scalone S, Comaro E, Talamini R, Mastorci K, Lombardi D, Perin T, Carbone A, Veronesi A, Crivellari D, Dolcetti R. Muraro E, et al. Among authors: dolcetti r. Breast Cancer Res. 2011;13(6):R117. doi: 10.1186/bcr3060. Breast Cancer Res. 2011. PMID: 22112244 Free PMC article.
272 results